Table 1. Distribution of clinical data for the overall sample and stratified by the occurrence of prodromal symptoms.
A P-value of <0.05 was considered statistically significant. Data presented as N (%)
| Total (N) | Prodromal symptoms | P-value | ||
| Yes | No | |||
| Total (N) | 242 | 100 (41.3%) | 142 (58.7%) | - |
| Gender | ||||
| Male | 174 (71.9%) | 64 (64%) | 110 (77.5%) | 0.014 |
| Female | 68 (28.1%) | 36 (36%) | 32 (22.5%) | |
| Age | ||||
| <40 years | 21 (8.7%) | 10 (10%) | 11 (7.7%) | 0.446 |
| 41-60 years | 157 (64.9%) | 59 (59%) | 98 (69%) | |
| >60 years | 64 (26.4%) | 31 (31%) | 33 (23.2%) | |
| Married | 239 (98.8%) | 99 (99%) | 140 (98.6%) | 0.425 |
| Employed | 110 (45.5%) | 37 (37%) | 73 (51.4%) | 0.009 |
| Diagnose | ||||
| ST-segment elevation myocardial infarction | 179 (74%) | 77 (77%) | 102 (71.8%) | 0.486 |
| Non-ST-segment elevation myocardial infarction | 63 (26%) | 23 (23%) | 40 (28.2%) | |
| Medical history | ||||
| Diabetes mellitus | 66 (27.3%) | 39 (39%) | 27 (19%) | 0.005 |
| Hypertension | 122 (50.4%) | 45 (45%) | 77 (54.2%) | 0.171 |
| Smoking | 54 (22.3%) | 15 (15%) | 39 (27.5%) | 0.086 |
| Ischemic heart disease | 38 (15.7%) | 23 (23%) | 15 (10.6%) | <0.001 |